Liquid Biopsy Symposium 2026
The Evolving Role of Liquid Biopsy in Cancer Management (Roche & Foundation Medicine, Zurich)
The symposium focused on the critical role of analyzing circulating tumor DNA (ctDNA) and Minimal Residual Disease (MRD) to enable dynamic, personalized, and early-stage molecular interventions in oncology.